2015
Novel Oral Anticoagulants: Efficacy, Laboratory Measurement, and Approaches to Emergent Reversal
Gehrie E, Tormey C. Novel Oral Anticoagulants: Efficacy, Laboratory Measurement, and Approaches to Emergent Reversal. Archives Of Pathology & Laboratory Medicine 2015, 139: 687-92. PMID: 25927153, DOI: 10.5858/arpa.2013-0677-rs.Peer-Reviewed Original ResearchConceptsNovel oral anticoagulantsManagement of NOACOral direct thrombin inhibitorDirect factor Xa inhibitorVitamin K antagonistsDirect thrombin inhibitorFactor Xa inhibitorsCertain clinical circumstancesOral anticoagulationWarfarin effectivenessK antagonistsOral anticoagulantsClinical efficacySafety profileEmergent reversalClinical circumstancesXa inhibitorsUS FoodDrug AdministrationThrombin inhibitorsNew drugsDrugsEfficacyInhibitorsLaboratory assays
2014
Clinical Applications of 4-Factor Prothrombin Complex Concentrate: A Practical Pathologist's Perspective
Unold D, Tormey CA. Clinical Applications of 4-Factor Prothrombin Complex Concentrate: A Practical Pathologist's Perspective. Archives Of Pathology & Laboratory Medicine 2014, 139: 1568-75. PMID: 26619030, DOI: 10.5858/arpa.2014-0366-rs.Peer-Reviewed Original ResearchConceptsProthrombin complex concentrateOral anticoagulantsComplex concentrateVitamin K antagonist reversalVitamin K antagonist therapyNovel oral anticoagulantsSpecific reversal agentsTreatment of hemorrhageDependent coagulation factorsAntagonist therapyLiver diseaseLabel indicationsAntagonist reversalTherapeutic dosesReversal agentsCoagulation factorsBleeding disorderRare coagulopathyVitamin KBlood bankersPathologist's perspectiveClinical applicationAnticoagulantsCoagulopathyBleeding